Semantic Scholar uses AI to extract papers important to this topic.
Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.
- Journal of medicinal chemistry
An orally active dual CysLT1 and CysLT2 antagonist possessing a distinctive structure which consists of triple bond and… (More)
Is this relevant?